CD4 and neoplasm: On the other hand, CD4+ regulatory T cells (Tregs), which are characterized by their immune-suppressive activity and by the expression of the transcription factor forkhead box P3 (FOXP3), play a pivotal role in promoting tumor progression by suppressing effective antitumor immunity [105,106].